Multiple Introductions of Salmonella enterica Serovar Typhi H58 with Reduced Fluoroquinolone Susceptibility into Chile

Emerg Infect Dis. 2020 Nov;26(11):2736-2740. doi: 10.3201/eid2611.201676.

Abstract

Salmonella enterica serovar Typhi H58, an antimicrobial-resistant lineage, is globally disseminated but has not been reported in Latin America. Genomic analysis revealed 3 independent introductions of Salmonella Typhi H58 with reduced fluoroquinolone susceptibility into Chile. Our findings highlight the utility of enhanced genomic surveillance for typhoid fever in this region.

Keywords: Chile; Salmonella Typhi H58; South America; antimicrobial resistance; bacteria; enteric diseases; fluoroquinolone resistance; genotyping; whole-genome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Chile / epidemiology
  • Drug Resistance, Bacterial*
  • Fluoroquinolones / pharmacology*
  • Humans
  • Microbial Sensitivity Tests
  • Salmonella typhi* / drug effects
  • Salmonella typhi* / genetics
  • Typhoid Fever* / epidemiology
  • Typhoid Fever* / microbiology

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones